aTyr Pharma, Inc. (ATYR)
0.7486
+0.01
(+0.78%)
USD |
NASDAQ |
Dec 29, 16:00
0.7403
-0.01
(-1.11%)
After-Hours: 20:00
aTyr Pharma Profit Margin (Quarterly): -13.55K% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Baxter International, Inc. | -1.80% |
| AIM ImmunoTech, Inc. | -12.63K% |
| Perspective Therapeutics, Inc. | -12.43K% |
| Protalix Biotherapeutics, Inc. | 13.19% |
| Armata Pharmaceuticals, Inc. | -2.30K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -103.0% |
| Return on Assets | -75.87% |
| Return on Invested Capital | -87.48% |
| Gross Profit Margin (Quarterly) | -104.7% |
| Operating Margin (Quarterly) | -14.08K% |
| Return on Net Operating Assets | -424.9% |